Chiara Ambrogio Lab
Chiara Ambrogio
In addition to leading her laboratory at IFOM, Chiara Ambrogio, PhD, is Full Professor of Molecular Biology at the University of Torino and Principal Investigator at the Molecular Biotechnology Center (MBC), where she leads a research program focused on oncogenic signaling and targeted therapies in cancer. Chiara Ambrogio received her degree in Medical Biotechnology and her PhD in Immunology and Cell Biology from the University of Torino.
RAS Oncogenic Signaling and Therapeutic Resistance
Cancer remains one of the leading causes of death worldwide, and despite remarkable therapeutic advances, many patients with solid tumors still face limited treatment options and poor long-term outcomes. One of the major challenges in oncology is the capacity of tumor cells to escape therapy through dynamic adaptation and molecular rewiring, ultimately undermining even highly targeted treatments. Addressing this challenge requires a deep mechanistic understanding of how cancers arise, evolve, and resist.